- Trials with a EudraCT protocol (78)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
78 result(s) found for: Severe Mental Illness.
Displaying page 1 of 4.
EudraCT Number: 2020-003718-11 | Sponsor Protocol Number: AFJ2020-2 | Start Date*: 2021-02-09 | |||||||||||
Sponsor Name:Mental Health Center Copenhagen | |||||||||||||
Full Title: The effectiveness of pharmacological treatment with the glucagon-like peptide-1 receptor agonist Liraglutide 3mg (Saxenda®) once-daily for weight management in forensic psychiatry; An Exploratory p... | |||||||||||||
Medical condition: Severe mental illness Obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004460-63 | Sponsor Protocol Number: EXPO | Start Date*: 2019-07-01 | ||||||||||||||||
Sponsor Name:South London and Maudsley NHS Foundation Trust [...] | ||||||||||||||||||
Full Title: Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO): An Open Label Randomised Controlled Trial of Injectable Depot Maintenance Buprenorphine versus Standard-Of-Care Oral Maintenance Opi... | ||||||||||||||||||
Medical condition: Opiod addiction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004647-37 | Sponsor Protocol Number: G0373 | Start Date*: 2006-11-06 | |||||||||||
Sponsor Name:Bangor University | |||||||||||||
Full Title: Folate Augmentation of Treatment – Evaluation of Depression: a randomised controlled trial | |||||||||||||
Medical condition: Individuals with moderate to severe depression according to ICD-10 criteria. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004064-35 | Sponsor Protocol Number: | Start Date*: 2018-04-17 |
Sponsor Name:Southern Health NHS Foundation Trust | ||
Full Title: Liraglutide and the management of overweight and obesity in people with schizophrenia: a pilot study | ||
Medical condition: Schizophrenia, schizoaffective disorder or first episode psychosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001618-34 | Sponsor Protocol Number: 1208.24 | Start Date*: 2006-12-11 | |||||||||||
Sponsor Name:BOEHRINGER ING. | |||||||||||||
Full Title: An eight-week, randomized, double-blind, two parallel groups, study to assess clinical response of Duloxetine 60 mg and 120 mg per day in patients hospitalized for severe depression | |||||||||||||
Medical condition: Treatment of severely depressed patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005695-27 | Sponsor Protocol Number: 8219 | Start Date*: 2008-12-02 | |||||||||||
Sponsor Name:Eli Lilly Nederland | |||||||||||||
Full Title: Comparing Problem Solving Treatment combined with duloxetine with Problem Solving Treatment alone for patients with major depressive disorder in primary care | |||||||||||||
Medical condition: Major depressive disorder (episode or recurrent), moderately severe as principal DSM-IV diagnosis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011228-73 | Sponsor Protocol Number: OCTUMI-03 | Start Date*: 2010-02-09 | |||||||||||
Sponsor Name:University of Oxford [...] | |||||||||||||
Full Title: A pilot study of Aripiprazole treatment for antipsychotic induced hyperprolactinaemia in young patients with severe mental illness and learning disabilities. | |||||||||||||
Medical condition: Antipsychotic induced hyperprolactinaemia | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002451-26 | Sponsor Protocol Number: 538264464328 | Start Date*: 2015-05-15 | |||||||||||
Sponsor Name:Department of Psychiatry, Helsinki University Central Hospital | |||||||||||||
Full Title: The effect of intranasal ketamine on suicidality in severely depressed and suicidal patients. Randomized, placebo-controlled study | |||||||||||||
Medical condition: Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003658-47 | Sponsor Protocol Number: F02207 GE 3 03 | Start Date*: 2006-11-21 | |||||||||||
Sponsor Name:Pierre Fabre Médicament - IRPF | |||||||||||||
Full Title: Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder. | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021044-17 | Sponsor Protocol Number: CLOCK_depression | Start Date*: 2010-08-11 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: The effect of agomelatine on CLOCK gene expression in patients with major depressive disorder and healthy controls: an exploratory study. | |||||||||||||
Medical condition: Major depressive disorder (MDD), Seasonal affective disorder (subtype of MDD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005476-41 | Sponsor Protocol Number: MMHSCT1096 | Start Date*: 2012-05-18 | |||||||||||
Sponsor Name:Manchester Mental Health and Social Care Trust | |||||||||||||
Full Title: Ketamine augmentation of ECT to improve outcomes in depression | |||||||||||||
Medical condition: Depressive disorder requiring treatment with electroconvulsive treatment (ECT) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001692-39 | Sponsor Protocol Number: CFTY720DDE06 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Novartis Pharma GmbH | ||||||||||||||||||
Full Title: A 21-week, multicenter, open label study to evaluate the safety and tolerability profile of the combination of a SSRI or SNRI antidepressive therapy with oral fingolimod in the treatment of RRMS pa... | ||||||||||||||||||
Medical condition: Multiple Sclerosis Depression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-004294-87 | Sponsor Protocol Number: 1,2 | Start Date*: 2011-11-15 | |||||||||||
Sponsor Name:Per Klausen Fink | |||||||||||||
Full Title: Treatment of multi-organ bodily distress syndrome. A double-blinded placebo controlled trial of the effect of Imipramine (STreSS-3) | |||||||||||||
Medical condition: F 45 Somatisation disorder and related disorders. Bodily distress syndrome is a new diagnosis that resembles F 45 Somatisation disorder, but with a more specific set of diagnostic criteria. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004579-37 | Sponsor Protocol Number: MZ12-PCP-PalenicekTomas-A | Start Date*: 2014-06-18 |
Sponsor Name:National Institute of Mental Health | ||
Full Title: Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI | ||
Medical condition: Inclusion criteria: a) Men and women at age between 28 and 65 years b) healthy volunteers with negative psychiatric history (severe mental illnesses that meet the criteria of ICD 10 F0.X - F99.X) ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001997-70 | Sponsor Protocol Number: EXCELLENCE/0421/0543v1 | Start Date*: 2022-11-16 | ||||||||||||||||||||||||||
Sponsor Name:University of Cyprus | ||||||||||||||||||||||||||||
Full Title: Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD) | ||||||||||||||||||||||||||||
Medical condition: Methadone and buprenorphine comprise a first-line, evidence-based opioid substitution treatment (OST) for OUD patients. Unfortunately, retention and adherence to OST treatment is currently a major ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: CY (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003637-41 | Sponsor Protocol Number: BIOEU001.00 | Start Date*: 2005-10-26 |
Sponsor Name:Biopure Corporation | ||
Full Title: A Phase II, Multi-Center, Single-Blinded, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Hemoglobin-Based Oxygen Carrier-201 (HBOC-201, hemoglobin-glutamer-250 (bovine)]) on Wo... | ||
Medical condition: Wound Healing in Patients with Peripheral Vascular Disease and Who are Undergoing a Lower Limb Amputation due to Critical Lower Limb Ischemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001890-15 | Sponsor Protocol Number: SD-809-C-18 | Start Date*: 2014-11-12 |
Sponsor Name:Auspex Pharmaceuticals, Inc. | ||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF SD-809 (DEUTETRABENAZINE) FOR THE TREATMENT OF MODERATE TO SEVERE TARDIVE DYSKINESIA | ||
Medical condition: Tardive Dyskinesia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) PL (Completed) SK (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-015165-31 | Sponsor Protocol Number: EME-08/43/39 | Start Date*: 2010-07-16 |
Sponsor Name:Northumberland, Tyne and Wear NHS Foundation Trust | ||
Full Title: Antiglucocorticoid augmentation of antiDepressants in Depression: a double-blind, randomised, placebo-controlled, parallel-group trial | ||
Medical condition: depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022307-22 | Sponsor Protocol Number: BergenPsychosisProject2 | Start Date*: 2011-04-14 | |||||||||||
Sponsor Name:Haukeland University Hospital, Division of Psychiatry | |||||||||||||
Full Title: The Bergen Psychosis Project 2 | |||||||||||||
Medical condition: Patients with schizophrenia and related non-affective psychotic disorders, corresponding to ICD-10 diagnoses F10.5-19.5, and F20-29. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003466-33 | Sponsor Protocol Number: 1103-011 | Start Date*: 2013-05-17 | |||||||||||
Sponsor Name:Mental Health Services North Holland North | |||||||||||||
Full Title: Memantine Add-On Therapy to Clozapine | |||||||||||||
Medical condition: Cognitive functioning, severity of psychopathology and treatment response (positive symptoms and negative symptoms of schizophrenia), depressive symptoms, social cognition, obsessive-compulsive sy... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.